Northern Trust’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-83,753
| Closed | -$56K | – | 4351 |
|
|
2017
Q4 | $56K | Buy |
83,753
+3,687
| +5% | +$1.86K | ﹤0.01% | 4060 |
|
|
2017
Q3 | $25K | Buy |
80,066
+3,879
| +5% | +$1.36K | ﹤0.01% | 4138 |
|
|
2017
Q2 | $34K | Sell |
76,187
-623
| -0.8% | -$453 | ﹤0.01% | 4127 |
|
|
2017
Q1 | $92K | Buy |
76,810
+4,138
| +6% | +$5.17K | ﹤0.01% | 3969 |
|
|
2016
Q4 | $96K | Buy |
72,672
+7,534
| +12% | +$13.1K | ﹤0.01% | 3913 |
|
|
2016
Q3 | $137K | Buy |
65,138
+4,833
| +8% | +$9.56K | ﹤0.01% | 3824 |
|
|
2016
Q2 | $98K | Sell |
60,305
-5,846
| -9% | -$11.2K | ﹤0.01% | 3895 |
|
|
2016
Q1 | $92K | Sell |
66,151
-42,717
| -39% | -$41.7K | ﹤0.01% | 3923 |
|
|
2015
Q4 | $132K | Buy |
108,868
+20
| +0% | +$64 | ﹤0.01% | 3873 |
|
|
2015
Q3 | $809K | Sell |
108,848
-162,466
| -60% | -$1.24M | ﹤0.01% | 3371 |
|
|
2015
Q2 | $1.94M | Sell |
271,314
-23,437
| -8% | -$183K | ﹤0.01% | 3074 |
|
|
2015
Q1 | $2.53M | Buy |
294,751
+760
| +0.3% | +$6.8K | ﹤0.01% | 2984 |
|
|
2014
Q4 | $2.93M | Buy |
293,991
+16,056
| +6% | +$137K | ﹤0.01% | 2846 |
|
|
2014
Q3 | $2.75M | Sell |
277,935
-17,836
| -6% | -$264K | ﹤0.01% | 2889 |
|
|
2014
Q2 | $5.12M | Sell |
295,771
-23,522
| -7% | -$383K | ﹤0.01% | 2501 |
|
|
2014
Q1 | $5.66M | Sell |
319,293
-21,498
| -6% | -$416K | ﹤0.01% | 2474 |
|
|
2013
Q4 | $6.24M | Buy |
340,791
+2,435
| +0.7% | +$46K | ﹤0.01% | 2403 |
|
|
2013
Q3 | $9.07M | Buy |
338,356
+66,725
| +25% | +$1.43M | ﹤0.01% | 2095 |
|
|
2013
Q2 | $5.01M | Buy |
+271,631
| New | +$4.8M | ﹤0.01% | 2418 |
|
Northern Trust's RPRX Position: Q1 2018 in Review
Northern Trust sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 83,753 shares — an estimated $56K sold.
Northern Trust first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $9.07M in Q3 2013. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.
- Northern Trust reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
- Northern Trust sold 83,753 Repros Therapeutics Inc. shares in Q1 2018, an estimated $56K.
- Northern Trust first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
- Northern Trust's Repros Therapeutics Inc. position peaked at $9.07M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.
Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.